Advertisement

Immunocompetence and Malignancy

  • Cornelis J. M. Melief
  • Robert S. Schwartz
Chapter
Part of the Cancer, A Comprehensive Treatise book series (C)

Abstract

In June of 1908, Paul Ehrlich, the founder of immunology, lectured at the University of Amsterdam on the subject of cancer. His remarks included the following: “the understanding of natural immunity really represents the key to carcinoma.... I have acquired the firm conviction that natural immunity does not depend on the presence of anti-microbial materials, but rather, it depends on purely cellular activities. I am certain that, in the enormously complicated course of fetal and post-fetal development, aberrant cells become unusually common. Fortunately, in the majority of people, they remain completely latent thanks to the organism’s positive mechanisms. If such mechanisms did not exist, one might expect carcinomas to have an enormous frequency. These cells may live in a latent state for 20, 30 or 40 years before changing to a significant tumor. This means, in light of my theory, that there has been a diminution of some vital cell activity [which] allows the rapid, parasitic growth of certain cells” (Ehrlich, 1957).*

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Alexander, P., 1972, Foetal “antigens” in cancer, Nature (Lond.) 235: 137.Google Scholar
  2. Allison, A. C., 1970, Tumour development following immunosuppression, Proc. Roy. Soc. Med. 63: 1077.PubMedGoogle Scholar
  3. Allison, A. C., And Law, L. W., 1968, Effects of antilymphocyte serum on virus oncogenesis, Proc. Soc. Exp. Biol. Med. 127: 207.PubMedGoogle Scholar
  4. Allison, A. C., And Taylor, R. B., 1967, Observations on thymectomy and carcinogenesis, Cancer Res. 27: 703.PubMedGoogle Scholar
  5. Allison, A. C., Berman, L. D., And Levey, R. H., 1967, Increased tumour induction by adenovirus type 12 in thymectomized mice and mice treated with antilymphocyte serum, Nature (Lond.) 215: 185.Google Scholar
  6. Amiet, A., 1963, Aldrich’s syndrome: A report of two cases, Ann. Paediat. 201: 515.Google Scholar
  7. Ammann, A. J., And Hong, R., 1971, Selective IgA deficiency: Presentation of 30 cases and a review of the literature, Medicine 50: 223.PubMedGoogle Scholar
  8. Ammann, P., Lopez, R., And Butler, R., 1965, Das Ataxia-telangiecktasie-syndrom (Louis-Bar syndrom) aus immunologischer Sicht, Heiv. Paediat. Acta 20: 137.Google Scholar
  9. Andrews, E. J., 1971, Evidence of the nonimmune regression of chemically induced papillomas in mouse skin, J. Natl. Cancer Inst. 47: 653.PubMedGoogle Scholar
  10. Armstrong, M. Y. K., Gleichmann, E., Gleichmann, H., Beldotti, L., And Andre-Schwartz, R. S., 1970, Chronic allogeneic disease. II. Development of lymphomas, J. Exp. Med. 132: 417.Google Scholar
  11. Armstrong, M. Y. K., Ruddle, N. H., Lipman, M. B., And Richards, F. F., 1973, Tumor induction by immunologically activated murine leukemia virus, J. Exp. Med. 137: 1163.Google Scholar
  12. Arseneau, J. C., Sponzo, R. W., Levin, D. L., Schnipper, L. E., Bonner, H., Young, R. C., Canellos, G. P., Johnson, R. E., And Devita, V. T., 1972, Nonlymphomatous malignant tumors complicating Hodgkin’s disease, New Engl. J. Med. 287: 1119.PubMedGoogle Scholar
  13. Baker, P. J., Barth, R. F., Stashok, P. W., And Amsbaugh, D. F., 1970, Enhancement of the antibody response to type Iii pneumococcal polysaccharide in mice treated with antilymphocyte serum, J. Immunol. 104: 1313.PubMedGoogle Scholar
  14. Ball, J. K., 1970, Immunosuppression and carcinogenesis: Contrasting effects with 7,12-dimethylbenz (a) anthracene benz (a) pyrene and 3-methylcholanthrene, J. Natl. Cancer Inst. 44: 1.PubMedGoogle Scholar
  15. Balner, H., And Dersjant, H., 1966, Neonatal thymectomy and tumor induction with methylcholan-threne in mice, J. Natl. Cancer Inst. 36: 513.PubMedGoogle Scholar
  16. Balner, H., And Dersjant, H., 1969, Increased oncogenic effect of methylcholanthrene after treatment with antilymphocyte serum, Nature (Lond.) 224: 376.Google Scholar
  17. Bansal, S. C., And Sjögren, H. O., 1971, “Unblocking” serum activity in vitro in the polyoma system may correlate with antitumour effect of antiserum in vivo, Nature New Biol. 233:76.PubMedGoogle Scholar
  18. Bansal, S. C., And SJÖGren, H. O., 1973, Regression of polyoma tumor metastasis by combined unblocking and Bcg treatment: Correlation with induced alterations in tumor immunity status, Int. J. Cancer 12: 179.PubMedGoogle Scholar
  19. Bashour, B. N., Manger, K., And Rance, C. P., 1973, Malignant mixed mtillerian tumor of the cervix following cyclophosphamide therapy for nephrotic syndrome, J. Pediat. 82: 292.PubMedGoogle Scholar
  20. Bennett, M., And Steeves, R. A., 1970, Immunocompetent cell functions in mice infected with Friend leukemia virus, J. Natl. Cancer Inst. 44: 1107.PubMedGoogle Scholar
  21. Bermuth, G. V., Minielly, J. A., Logan, G. B., And Gleich, G. J., 1970, Hodgkin’s disease and thymic alymphoplasia in a 5 month old infant, Pediatrics 45: 792.Google Scholar
  22. Blair, P. B., 1971, Immunological aspects of the relationship between host and oncogenic virus in the mouse mammary tumor system, Israel J. Med. Sci. 7: 161.PubMedGoogle Scholar
  23. Blair, P. B., 1972, Effect of transient immunosuppression on host response to neonatally introduced oncogenic virus, Cancer Res. 32: 356.PubMedGoogle Scholar
  24. Boder, E., 1973, Ataxia-telangiectasia: Recent clinical and pathological observations, in: Proceedings of the Second International Workshop on Immunodeficiency Diseases in Man ( D. Bergsma and R. A. Good, eds.), The National Foundation, New York.Google Scholar
  25. Boder, E., And Sedgwick, R. P., 1963, Ataxia telangiectasia: A review of 101 cases, in: Cerebellum, Posture and Cerebral Palsy Little Club Clinics in Developmental Medicine No. 8, (G. E. Walsh, ed.), pp. 110–118, J. B. Lippincott, Philadelphia.Google Scholar
  26. Brand, M. M., And Marinkovich, V. A., 1969, Primary malignant reticulosis of the brain in Wiskott—Aldrich syndrome: Report of a case, Arch. Dis. Child. 44: 536.PubMedGoogle Scholar
  27. Brown, R. S., Haynes, H. A., Foley, H. T., Godwin, H. A., Berard, C. W., And Carbone, P. P., 1967, Hodgkin’s disease: Immunologic, clinical and histologic features of 50 untreated patients, Ann. Int. Med. 67: 291.PubMedGoogle Scholar
  28. Bubenik, J., Perlmann, P., Helmstein, K., And Moberger, G., 1970, Cellular and humoral immune responses to human urinary bladder carcinomas, Int. J. Cancer 5: 310.PubMedGoogle Scholar
  29. Bullock, W. E., 1968, Studies of immune mechanisms in leprosy. I. Depression of delayed allergic responses to skin test antigens, New Engl. J. Med. 278: 298.Google Scholar
  30. Burnet, F. M., 1963, The evolution of bodily defense, Med. J. Austral. 2: 817.PubMedGoogle Scholar
  31. Burnet, F. M., 1970, The concept of immunological surveillance, Prog. Exp. Tumor Res. 13: 1.PubMedGoogle Scholar
  32. Burstein, N. A., And Allison, A. C., 1970, Effect of antilymphocyte serum on the appearance of reticular neoplasms in Sjl/J mice, Nature (Lond.) 225: 1139.Google Scholar
  33. Burstein, N. A., And Law, L. W., 1971, Neonatal thymectomy and nonviral mammary tumors in mice, Nature (Lond.) 231: 450.Google Scholar
  34. Burton, B. T., Krueger, K. K., And Bryan, F. A., 1971, National Registry of Long-Term Dialysis Patients, J. Am. Med. Assoc. 218: 718.Google Scholar
  35. Cantor, H., Asofsky, R., And Talal, N., 1970, Synergy among lymphoid cells mediating the graft versus host response. I. Synergy in graft versus host reactions produced by cells from Nzb/Bl mice, J. Exp. Med. 131: 223.PubMedCentralPubMedGoogle Scholar
  36. Castaigne, P., Gambier, J., And Brunet, P., 1969, Ataxie-telangiectasies, desordres immunitaires, lymphosarcomatose terminale chez deux frères, Presse Med. 77: 347.PubMedGoogle Scholar
  37. Cerelli, G. J., And Treat, R. C., 1969, The effect of antilymphocyte serum on the induction and growth of tumor in the adult mouse, Transplantation 8: 774.Google Scholar
  38. Chaptal, J., Rover, P., Jean, R., Alagille, D., Bonnet, H., Lagarde, E., Robinet, M., And Rieu, D., 1966, Syndrome de Wiskott–Aldrich avec survie prolongée (gans) évolution mortelle par thymosarcome, Arch. Franc. Pediat 23: 907.PubMedGoogle Scholar
  39. Chesterman, F. C., Gaugas, J. M., Hirsch, M. S., Rees, R. J. W., Harvey, J. F., And Gilchrist, C., 1969, Unexpected high incidence of tumours in thymectomized mice treated with anti-lymphocyte globulin and Mycobacterium leprae, Nature (Land.) 221: 1033.Google Scholar
  40. Chu, E. H. Y., Stjernsward, J., Clifford, P., And Klein, G., 1967, Reactivity of human lymphocytes against autochthonous and allogeneic normal and tumor cells in vitro, J. Natl. Cancer Inst. 39: 595.Google Scholar
  41. CLaman, H. N., And Chaperon, E. A., 1969, Immunologic complementation between thymus and marrow cells—A model for the two-cell theory of immunocompetence, Transpl. Rev. 1: 92.Google Scholar
  42. Cohen, A. M., Ketcham, A. S., And Morton, D. L., 1973, Tumor-specific cellular cytotoxicity to human sarcomas: Evidenke for a cell-mediated host immune response to a common sarcoma cell-surface antigen, J. Nad. Cancer Inst. 50: 585.Google Scholar
  43. Cohen, S. M., Headley, D. B., And Bryan, G. T., 1973, The effect of adult thymectomy and adult splenectomy on the production of leukemia and stomach neoplasms in mice by N-(4-(5-nitro-2furyl)-2-thiazolyl) acetamide, Cancer Res. 33: 637.PubMedGoogle Scholar
  44. Coleman, A., Leikin, S., AniÌ’ Guin, G. H., 1961, Aldrich’s syndrome, Clin. Proc. Child. Hosp. (Wash.) 17: 22.Google Scholar
  45. Cooper, M. D., Chase, H. P., Lowman, J. T., Krurt, W., And Good, R. A., 1968, Wiskott–Aldrich syndrome, Am. J. Med. 44: 499.PubMedGoogle Scholar
  46. Cooper, M. D., Lawton, A. R., And Bockman, D. E., 1971, Agammaglobulinemia with B lymphocytes: Specific defect of plasma-cell differentiation, Lancet 2: 791.PubMedGoogle Scholar
  47. Craig, S. R., And Rosenbery, E. W., 1971, Methotrexate-induced carcinoma? Arch. Dermatol. 103: 505.PubMedGoogle Scholar
  48. Custer, R. P., Outzen, H. C., Eaton, G. J., And Prehn, R. J., 1973, Does the absence of immunologic surveillance affect the tumor incidence in “nude” mice? First recorded spontaneous lymphoma in a “nude” mouse, J. Natl. Cancer Inst. 51: 707.PubMedGoogle Scholar
  49. Dammin, G. J., Couch, N. P., And Murray, J. E., 1957, Prolonged survival of skin homografts in uremic patients, Ann. N.Y. Acad. Sci. 64: 967.PubMedGoogle Scholar
  50. Defendi, V., And Roosa, R. A., 1964, The role of the thymus in carcinogenesis, in: The Thymus ( V. Defendi and D. Metcalf, eds.), p. 121, Wistar Institute Press, Philadelphia.Google Scholar
  51. Denlinger, R. H., Swenberg, J. A., Koestner, A., And Wechsler, W., 1973, Differential effect of immunosuppression on the induction of nervous system and bladder tumors by N-methyl N-nitrosurea, J. Natl. Cancer Inst. 50: 87.PubMedGoogle Scholar
  52. Denman, A. M., And Denman, E. J., 1970, Depletion of long-lived lymphocytes in old New Zealand Black mice, Clin. Exp. Immunol. 6: 457.PubMedCentralPubMedGoogle Scholar
  53. Dent, P., 1972, Immunosuppression by oncogenic viruses, Prog. Med. Virol. 14: 1.PubMedGoogle Scholar
  54. Dent, P. B., Peterson, R. D. A., And Good, R. A., 1965, A defect in cellular immunity during the incubation period of passage A leukemia in C3H mice, Proc. Soc. Exp. Biol. Med. 119: 869.PubMedGoogle Scholar
  55. Deodhar, S., 1972, Discussion, in: Conference on Immunology of Carcinogenesis, p. 217, National Cancer Institute Monograph 35, National Cancer Institute, Bethesda, Md.Google Scholar
  56. Digeorge, A. M., 1968, Congenital absence of the thymus and its immunologic consequences: Concurrence with congenital hypoparathyroidism, in: Immunologic Deficiency Diseases of Man ( R. A. Good and D. Bergsma, eds.), pp. 116–123, The National Foundation, New York.Google Scholar
  57. Doell, R. G., Devaux ST. Cyr, C., And Grabar, P., 1967, Immune reactivity prior to development of thymic lymphoma in C57B1 mice, Int. J. Cancer 2: 103.PubMedGoogle Scholar
  58. DorÉ, J. F., Schneider, M., And MathÉ, G., 1969, Réactions immunitaires chez les souris Akr leucemiques ou preleucemiques, Rev. Franc. Etudes Clin. Biol. 14: 1003.PubMedGoogle Scholar
  59. Douglas, S. D., Goldberg, L. S., And Fudenberg, H. H., 1970, Clinical, serologic and leukocyte function studies on patients with idiopathic “acquired” agammaglobulinemia and their families, Am. J. Med. 48: 48.PubMedGoogle Scholar
  60. Dunn, H. G., Meuwissen, H., Livingston, C. S., And Pump, K. K., 1964, Ataxia telangiectasia, Canad. Med. Assoc. J. 91: 1106.PubMedGoogle Scholar
  61. East, J., 1970, Immunopathology and neoplasms in Nzb and Sjl/J mice, Prog. Exp. Tumor Res. 13: 88.Google Scholar
  62. East, J., And.Harvey, J. J., 1968, The differential action of neoatal thymectomy in mice infected with murine sarcoma virus-Harvey (Msv-H), Int. J. Cancer 3: 614.Google Scholar
  63. Editorial, 1969, Hypogammaglobulinemia in the United Kingdom, Lancet 1: 163.Google Scholar
  64. Ehrlich, P., 1957, Uber den jetzigen Stand der Karzinomforschung, in: The Collected Papers of Paul Ehrlich, Vol. II, p. 550, Pergamon Press, London.Google Scholar
  65. Emery, C. W. A., 1924, Early pregnancy and epitheliomata, Brit. Med. J. 2: 1149.PubMedGoogle Scholar
  66. Falk, L. A., Wolfe, L. G., And Deinhardt, F., 1973, Herpesvirus saimiri: Experimental infection of squirrel monkeys (Saimiri sciureus), J. Natl. Cancer Inst. 51: 165.PubMedGoogle Scholar
  67. Fass, L., Herberman, R. B., And Ziegler, J. L., 1970, Cutaneous hypersensitivity reactions to autologous extracts of Burkitt’s lymphoma cells, New Engl. J. Med. 282: 776.PubMedGoogle Scholar
  68. Feigin, R. D., Vietti, T. J., Wyatt, R. G., Kaufman, D. G., And Smith, C. H., 1970, Ataxia telangiectasia with granulocytopenia, J. Pediat. 77: 431.PubMedGoogle Scholar
  69. Fisher, J. C., Davis, R. C., And Mannick, J. A., 1970, The effects of immunosuppression on the induction and immunogenicity of chemically induced sarcomas, Surgery 68: 150.PubMedGoogle Scholar
  70. Flanagan, S. P., 1966, “Nude,” a new hairless gene with pleiotropic effects, Genet. Res. (Carob.) 8:295.Google Scholar
  71. Foley, E. J., 1953, Antigenic properties of methylcholanthrene-induced tumors in mice of the strain of origin, Cancer Res. 13: 835.PubMedGoogle Scholar
  72. Forssman, O., And Herner, B., 1964, Acquired agammaglobulinaemia and malabsorption, Acta Med. Scand. 176: 779.PubMedGoogle Scholar
  73. Fraumeni, J. F., 1969, Constitutional disorders of Man Predisposing to Leukemia and Lymphoma, p. 221Google Scholar
  74. National Cancer Institute Monograph 32, National Cancer Institute, Bethesda, Md.Google Scholar
  75. Freeman, A. I., Sinks, L. F., And Cohen, M. M., 1970, Lymphosarcoma in siblings associated with cytogenetic abnormalities, immune deficiency and abnormal erythropoiesis, J. Pediat. 77: 996.PubMedGoogle Scholar
  76. Friedman, H., 1964, Distribution of antibody plaque forming cells in various tissues of several strains of mice injected with sheep erythrocytes, Proc. Soc. Exp. Biol. Med. 117: 526.PubMedGoogle Scholar
  77. Friedman, H., And Ceglowski, W. S., 1971, Defect in cellular immunity of leukemia virus—infected mice assessed by macrophage migration-inhibition assay, Proc. Soc. Exp. Biol. Med. 136: 154.PubMedGoogle Scholar
  78. Friedman, H., And Ceglowski, W. S., 1973, Cellular immunity and leukemia virus infection, in: Virus Tumorigenesis and Immunogenesis (W. S. Ceglowski and H. Friedman, eds.), p. 299, Academic Press, New York and London.Google Scholar
  79. Friedman, H., Melnick, H., Mills, L., And Ceglowski, W. S., 1973, Depressed allograf t immunity in leukemia virus infected mice, Transpi. Proc. 5: 981.Google Scholar
  80. Friedrich-Freska, H., And Hoffman, M., 1969, Immunological defense against preneoplastic stages of diethyl-nitrosamine-induced carcinomas in rat liver, Nature (Land.) 223: 1162.Google Scholar
  81. Fudenberg, H., And Solomon, A., 1961, “Acquired agammaglobulinemia” with auto-immune hemolytic disease: Graft versus host reaction? Vox Sang. 6:68.Google Scholar
  82. Furth, J., Kunii, A., Ioachim, H., Sanel, F. T., And Moy, P., 1966, Parallel observations on the role of the thymus in leukaemogenesis, immunocompetence and lymphopoiesis, in: The Thymus: Experimental and Clinical Studies (G. E. W. Wolstenholme and R. Potter, eds.), p. 288, Little, Brown, Boston.Google Scholar
  83. Gelfand, M. E., And Steinberg, A. D., 1973, Mechanism of allograft rejection in New Zealand mice. I. Cell synergy and its age-dependent loss, J. Immunol. 110: 1652.PubMedGoogle Scholar
  84. Gershon, R. K., Cohen, P., Hencin, R., And Liebhaber, S. A., 1972, Suppressor T cells, J. Immunol. 108: 586.PubMedGoogle Scholar
  85. Giovanella, B. C., Liegel, J., And Heidelberger, C., 1970, The refractoriness of the skin of hairless mice to chemical carcinogenesis, Cancer Res. 30: 2590.PubMedGoogle Scholar
  86. Gitlin, D., And Janeway, C. A., 1956, Agammaglobulinemia, congenital, acquired and transient forms, Prog. Hematol. 1: 318.PubMedGoogle Scholar
  87. GooD, R. A., 1972, Relations between immunity and malignancy, Proc. Natl. Acad. Sci. 69: 1026.Google Scholar
  88. Gotoff, S. P., Amirmokri, E., And Liebner, E. J., 1967, Ataxia telangiectasia: Neoplasia, untoward response to x-irradiation and tuberous sclerosis, Am. J. Dis. Child. 114: 617.PubMedGoogle Scholar
  89. Gottlieb, C. F., Perkins, E. H., And Makinodan, T., 1972, Genetic regulation of the thymus dependent humoral immune response in leukemia prone Akr (H-2 k ) and nonleukemic C3H (H-2 k ) mice, J. Immunol. 109: 974.PubMedGoogle Scholar
  90. Grant, G. A., And Miller, J. F. A. P., 1965, Effect of neonatal thymectomy on the induction of sarcomata in C57BL mice, Nature (Lond.) 205: 1124.Google Scholar
  91. Grant, G. A., And Roe, F. J. C., 1969, Effect of germ free status and antilymphocyte serum on induction of various tumors in mice by a chemical carcinogen given at birth, Nature (Lond.) 223: 1060.Google Scholar
  92. Green, T., Liturn, S., Adlersberg, R., And Rubin, I., 1966, Hypogammaglobulinemia with late development of a lymphosarcoma: A case report, Arch. Int. Med. 118: 592.Google Scholar
  93. Greenwood, B. M., Bradley-Moore, A. M., Palit, A., And Brijceson, A. D. M., 1972, Immunosuppression in children with malaria, Lancet 1: 1969.Google Scholar
  94. Gross, L., 1959, Effect of thymectomy on development of leukemia in C3H mice inoculated with leukemic “passage” virus, Proc. Soc. Exp. Biol. Med. 100: 325.PubMedGoogle Scholar
  95. Gross, L., 1970, Oncogenic Viruses, Pergamon Press, New York.Google Scholar
  96. Guttman, R. D., And Lindquist, P. R., 1969, Renal transplantation in inbred rats: Reduction of allograft immunogenicity by cytotoxic drug pretreatment of donors, Transplantation 8: 490.Google Scholar
  97. Haerer, A. F., Jackson, J. F., And Evers, C. G., 1969, Ataxia telangiectasia with gastric carcinoma, J. Am. Med. Assoc. 210: 1884.Google Scholar
  98. Hanna, M. G., Nettesheim, P., And Ogden, L., 1967, Reduced immune potential of aged mice: Significance of morphologic changes in lymphatic tissue, Proc. Soc. Exp. Biol. Med. 125: 882.PubMedGoogle Scholar
  99. Haran-Ghera, N., Ben Yaakov, M., Peled, A., And Bentwich, Z., 1973, Immune status of Sjl/J mice in relation to age and spontaneous tumor development, J. Natl. Cancer Inst. 50: 1227.Google Scholar
  100. Hargis, B. J., And Malkiel, S., 1972, The immunocapacity of the Akr mouse, Cancer Res. 32: 291.Google Scholar
  101. Harris, C. C., 1971, Malignancy during methotrexate and steroid therapy for psoriasis, Arch. Dermatol. 103: 501.Google Scholar
  102. Harris, J., Jessop, J. D., And DE Saintonge, D. M. C., 1971, Further experience with azathioprine in rheumatoid arthritis, Brit. Med. J. 4: 463.PubMedGoogle Scholar
  103. Hecht, F., Koler, R. D., Rigas, D. A., Dahnke, G. S., Case, M. P., Tisdale, V., And Miller, R. W., 1966, Leukemia and lymphocytes in ataxia telangiectasia, Lancet 2: 1193.Google Scholar
  104. Hecht, F., Mccaw, B. K., And Koler, R. D., 1973, Ataxia-telangiectasia—Clonal growth of translocation lymphocytes, New Engl. J. Med. 289: 286.PubMedGoogle Scholar
  105. Hechtel, M., Dishon, T., And Braun, W., 1965, Hemolysin formation in newborn mice of different strains, Proc. Soc. Exp. Biol. Med. 120: 728.PubMedGoogle Scholar
  106. HellstrÖM, I., And HellstrÖM, K. E., 1973, Some recent studies on cellular immunity to human melanomas, Fed. Proc. 32: 156.PubMedGoogle Scholar
  107. HellstrÖM, I., HellstrÖM, K. E., Evans, C. A., Heppner, G. H., Pierce, G. E., And Yang, J. P. S., 1969, Serum-mediated protection of neoplastic cells from inhibition by lymphocytes immune to their tumor-specific antigens, Proc. Natl. Acad. Sci. 62: 362.PubMedGoogle Scholar
  108. HellstrÖM, I., HellstrÖM, K. E., And Shepard, T. H., 1970a, Cell-mediated immunity against antigens common to human colonic carcinomas and fetal gut epithelium, Int. J. Cancer 6: 346.PubMedGoogle Scholar
  109. HellstrÖM, I., HellstrÖM, K. E., Bill, A. H., Pierce, G. E., And Yang, J. P. S., 1970b, Studies on cellular immunity to human neuroblastoma cells, Int. J. Cancer 6: 172.PubMedGoogle Scholar
  110. HellstrÖM, I., HellstrÖM, K. E., Sjögren, H. O., and Warner, G. A., 1971, Serum factors in tumor-free patients cancelling the blocking of cell-mediated immunity, Int. J. Cancer 8: 185.PubMedGoogle Scholar
  111. HellstrÖM, K. E., And HellstrÖM, I., 1969, Cellular immunity against tumor antigens, Advan. Cancer Res. 12: 167.Google Scholar
  112. Heppner, G. H., Wood, P. C., And Weiss, D. W., 1968, Studies on the role of the thymus in viral tumorigenesis. I. Effect of thymectomy on induction of hyperplastic alveolar nodules and mammary tumors in Balb/c and C3H mice, Israel J. Med. Sci. 4: 1195.PubMedGoogle Scholar
  113. Herberman, R. B., 1973, In vivo and in vitro assays of cellular immunity to human tumor antigens, Fed. Proc. 32: 160.Google Scholar
  114. Hermans, P. C., And Huizenga, K. A., 1972, Association of gastric carcinoma with idiopathic late-onset immunoglobulin deficiency, Ann. Int. Med. 76: 605.PubMedGoogle Scholar
  115. Hersh, E. M., Whitecar, J. P., Mccredie, K. B., Bodey, G. P., And Freireich, E. J., 1971, Chemotherapy, immunocompetence, immunosuppression and prognosis in acute leukemia, New Engl. J. Med. 285: 1211.PubMedGoogle Scholar
  116. Hirsch, M. S., And Murphy, F. A., 1968, Effects of antithymocyte serum on Rauscher virus infection of mice, Nature (Lond.) 218: 478.Google Scholar
  117. Hirsch, M. S., Allison, A. C., And Harvey, J. J., 1969, Immune complexes in mice infected neonatally with Moloney leukemogenic and murine sarcoma viruses, Nature (Lond.) 223: 739.Google Scholar
  118. Hirsch, M. S., Black, P. H., Tracy, G. S., Leibowitz, S., And Swartz, R. S., 1970, Leukemia virus activation in chronic allogeneic disease, Proc. Natl. Acad. Sci. 67: 1914.PubMedGoogle Scholar
  119. Hirsch, M. S., Black, P. H., Wood, M. L., And Monaco, A. P., 1973a, Effects of pyran copolymer on leukemogenesis in immunosuppressed Akr mice, J. Immunol. 111: 91.PubMedGoogle Scholar
  120. Hirsch, M. S., Ellis, D. A., Black, P. H., Monaco, A. P., And Wood, M. L., 19736, Leukemia virus activation during homograft rejection, Science 180: 500.Google Scholar
  121. Hirschhorn, K.,Schreibman, R. R., Bach, F. H., And Siltzbach, L. E., 1964, In vitro studies of lymphocytes from patients with sarcoidosis and lymphoproliferative diseases, Lancet 2: 842.Google Scholar
  122. Hitzig, W. G., 1968, The Swiss type of agammaglobulinemia, in: Immunologic Deficiency Diseases in Man ( R. A. Good and D. Bergsma, eds.), p. 53, The National Foundation, New. York.Google Scholar
  123. Hoerni, B., And Laporte, G., 1970, Immunological disorders in the aetiology of lymphoreticular neoplasms, Rev. Europ. Etud. Clin. Biol. 15: 841.Google Scholar
  124. Hoover, R., And Fraumeni, J. F., JR., 1973, Risk of cancer in renal-transplant recipients, Lancet 2: 55.PubMedGoogle Scholar
  125. Hoyer, J. R., Cooper, M. C., Gabrielson, A. E., And R. A., 1968, Lymphopenic forms of congenital immunologic deficiency diseases, Medicine 47: 201.PubMedGoogle Scholar
  126. Huber, F., 1968, Experience with various immunologic deficiencies in Holland, in: Immunologic Deficiency Diseases in Man (R. A. Good and D. Bergsma, eds.) p. 53, The National Foundation, New York.Google Scholar
  127. Johnson, E. A., Reed, N. D., Jutila, J. W., And Hill, W. D., 1974, Submitted for publication. Johnson, S., 1968, Effect of thymectomy on the induction of skin tumors by dibenzanthracene and of breast tumors by dimethylbenzanthracene in mice of the IF strain, Brit. J. Cancer 22: 755.Google Scholar
  128. Judd, K. P., Stephens, K., And Trentin, J. J., 1971, Effects of heterologous antilymphocyte antibody on the development of spontaneous and transplanted lymphoma in Akr mice, Cancer 27: 1161.PubMedGoogle Scholar
  129. Jung, K. S. K., Hoffman, G. C., And Lonsdale, D., 1969, Lymphoproliferative lesion in congenital thymic aplasia associated with agammaglobulinemia, Am. J. Clin. Pathol. 52: 726.Google Scholar
  130. Kadowaki, J. I., Thompson, R. I., Zuelzer, W. W., Wooley, P. V., Brough, A. J., And Gruber, D., 1965, XX/XY lymphoid chimaerism in congenital immunological deficiency syndrome with thymic alymphoplasia, Lancet 2: 1152.PubMedGoogle Scholar
  131. Kaplan, H. S., 1971, Role of immunologic disturbance in human oncogenesis: Some facts and fancies, Brit. J. Cancer 25: 620.PubMedGoogle Scholar
  132. Katz, D. H., And Benacerraf, B., 1972, The regulatory influence of activated T cells on B cell responses to antigen, Advan. Immunol. 15:1.11Google Scholar
  133. Kay, S., Frable, W. J., And Hume, D. M., 1970, Cervical dysplasia and cancer developing in women on immunosuppression therapy for renal homotransplantation, Cancer 26: 1048.PubMedGoogle Scholar
  134. Kildeberg, P., 1961, The Aldrich syndrome: Report of a case and discussion of pathogenesis, Prediatrics 27:362.Google Scholar
  135. Kirschstein, R., Rabson, A. S., And Peters, E. A., 1964, Oncogenic activity of adenovirus 12 in thymectomized Balb/c and C3H/HeN mice, Proc. Soc. Exp. Biol. Med. 117: 198.PubMedGoogle Scholar
  136. Klein, E., 1972, Tumor immunology, escape mechanisms, Ann. Inst. Pasteur 122: 593.Google Scholar
  137. Klein, G., 1966, Tumor antigens. Ann. Rev. Microbiol. 20: 223.Google Scholar
  138. Klein, G., 1969, Experimental studies in tumor immunology, Fed. Proc. 28: 1739.PubMedGoogle Scholar
  139. Klein, G., 1973, Tumor immunology, Transpl. Proc. 5: 31.Google Scholar
  140. Koldovsky, P., 1969, Tumor Specific Transplantation Antigen, Springer, New York.Google Scholar
  141. Kouttab, N. M., Jutila, J. W., And Reed, N. D.,Submitted for publication.Google Scholar
  142. Krueger, G. R. F., 1972, Chronic immunosuppression and lymphomagenesis in man and mice, in: Conference on Immunology of Carcinogenesis, p. 138, National Cancer Institute Monograph 35, National Cancer Institute, Bethesda, Md.Google Scholar
  143. Kyle, R. A., Pierre, R. V., And Bayrd, E. D., 1970, Multiple myeloma and acute myelomonocytic leukemia, New Engl. J. Med. 283: 1121.PubMedGoogle Scholar
  144. Lampert, F., 1969, Akute lymphoblastische Leukämie bei Geschwistern mit progressiver Kleinhernataxie (Louis-Bar syndrom), Deutsch. Med. Wschr. 94: 217.PubMedGoogle Scholar
  145. Lance, E. M., Medawar, P. B., And Taut, R. N., 1973, Antilymphocyte serum, Advan. Immunol. 17: 2.Google Scholar
  146. Lappe, M. A., And Blair, P. B., 1970, Interference with mammary tumorigenesis by antilymphocyte serum, Proc. Am. Assoc. Cancer Res. 11: 47.Google Scholar
  147. Lappe, M. A., And Prehn, R. J., 1970, The predictive value of skin allograft survival times during the development of urethan-induced lung adenomas in Balb/c mice, Cancer Res. 30: 1357.PubMedGoogle Scholar
  148. Law, L. W., 1966, Studies of thymic function with emphasis on the role of the thymus in oncogenesis, Cancer Res. 26: 551.PubMedGoogle Scholar
  149. Law, L., 1969, Studies of the significance of tumor antigens in induction and repression of neoplastic disease, Cancer Res. 29: 1.PubMedGoogle Scholar
  150. Law, L. W., 1970a, Effects of antilymphocyte serum on the induction of neoplasms of lymphoreticular tissues, Fed. Proc. 29: 171.PubMedGoogle Scholar
  151. Law, L. W., 19706, Studies of tumor antigens and tumor specific immune mechanisms in experimental systems, Transpl. Proc. 2: 117.Google Scholar
  152. Law, L. W., And Chang, S. S., 1971, Effects of antilymphocyte serum (Als) on the induction of lymphocytic leukemia in mice, Proc. Soc. Exp. Biol. Med. 136: 420.PubMedGoogle Scholar
  153. Law, L. W., And Miller, J. H., 1950, The influence of thymectomy on the incidence of carcinogen-induced leukemia in strain Dba mice, J. Natl. Cancer Inst. 11: 425.PubMedGoogle Scholar
  154. Law, L. W., And Ting, R. C., 1965, Immunologic competence and induction of neoplasms by polyoma virus, Proc. Soc. Exp. Biol. Med. 119: 823.PubMedGoogle Scholar
  155. Lee, A. K. Y., Mackay, 1. R., Rowley, M. J., And Yap, C. Y., 1971, Measurement of antibody-producing capacity to flagellin in man. IV. Studies in autoimmune disease, allergy and after azathioprine treatment, Clin. Exp. Immunol. 9: 507.Google Scholar
  156. Legge, J. S., And Austing, C. M., 1968, Antigen localization and the immune response as a function of age, Austral. J. Exp. Biol. Med. Sci. 46: 361.Google Scholar
  157. Leventhal, B. G., And Talal, N., 1970, Response of Nzb and Nzb/Nzw spleen cells to mitogenic agents, J. Immunol. 104: 918.PubMedGoogle Scholar
  158. Levine, B. B., And Vas, N. M., 1970, Effect of combinations of inbred strain, antigen, and antigen dose on immune responsiveness and reagin production in the mouse, Int. Arch. Allergy Appl. 39: 156.Google Scholar
  159. Lilly, F., 1968, The effect of histocompatibility-2 type on response to Friend leukemia virus in mice, J. Exp. Med. 127: 465.Google Scholar
  160. Lilly, F., 1972, Mouse leukemia: A model of a multiple gene disease, J. Natl. Cancer Inst. 49: 927.PubMedGoogle Scholar
  161. Lilly, F., And Pincus, T., 1973, Genetic control of murine viral leukemogenesis, Advan. Cancer Res. 17: 231.Google Scholar
  162. Lilly, F., Boyse, E. A., And Old, L. J., 1964, Genetic basis of susceptibility to viral leukemogenesis, Lancet 2: 1207.PubMedGoogle Scholar
  163. Lipsmeyer, E. A., 1972, Development of malignant cerebral lymphoma in a patient with systemic lupus erythematosus treated with immunosuppression, Arthritis. Rheum. 15: 183.PubMedGoogle Scholar
  164. Little, C. C., 1941, The genetics of tumor transplantation, in: Biology of the Laboratory Mouse ( G. D. Snell, ed.), pp. 279–309, Blakiston, Philadelphia.Google Scholar
  165. Makinodan, T., And Peterson, W. J., 1964, Growth and senescence of the primary antibody-forming potential of the spleen, J. Immunol. 93: 886.PubMedGoogle Scholar
  166. Malmgren, R. A., Bennison, B. E., And Mckinley, T. W., 1952, Reduced antibody titers in mice treated with carcinogenic and cancer chemotherapeutic agents, Proc. Soc. Exp. Biol. Med. 79: 484.PubMedGoogle Scholar
  167. Manning, D. D., Reed, N. D., And Shaffer, C. F., 1973, Maintenance of skin xenografts of widely divergent phylogenetic origin on congenitally athymic (nude) mice, J. Exp. Med. 138: 488.Google Scholar
  168. Manny, N., Rosenman, E., And Benbassat, J., 1972, Hazard of immunosuppressive therapy, Brit. Med. J. 2: 291.PubMedGoogle Scholar
  169. Martinez, C., 1964, Effect of early thymectomy on development of mammary tumours in mice, Nature (Lond.) 203: 1188.Google Scholar
  170. Mcdevitt, H. O., And Benacerraf, B., 1969, Genetic control of specific immune responses, Advan. Immunol. 11: 31.Google Scholar
  171. Mcendy, D. P., Boon, M. C., And Furth, J., 1944, On the role of thymus, spleen and gonads in the development of leukemia in a high leukemia stock of mice, Cancer Res. 4: 377.Google Scholar
  172. Mcewan, A., And Petty, L. G., 1972, Oncogenicity of immunosuppressive drugs, Lancet 1:326. Mcfarlin, D. E., Strober, W., And Waldmann, T. A., 1972, Ataxia telangiectasia, Medicine 51:281. Mckhann, C. F., 1969, Primary malignancy in patients undergoing immunosuppression for renalGoogle Scholar
  173. transplantation, Transplantation 8:209.Google Scholar
  174. Mckusick, V. A., And Cross, H. E., 1966, Ataxia telangiectasia and Swiss-type agammaglobulinemia, J. Am. Med. Assoc. 195:119.Google Scholar
  175. Metcalf, D., 1963, The fate of parental preleukemic cells in leukemia susceptible and leukemia resistant F1 hybrid mice, Cancer Res. 23: 1774.PubMedGoogle Scholar
  176. Metcalf, D., And Moulds, R., 1967, Immune responses in preleukemic and leukemic Akr mice, Int. J. Cancer 2: 53.PubMedGoogle Scholar
  177. Metcalf, D., Moulds, R., And Pike, B., 1966, Influence of the spleen and thymus on immune responses in aging mice, Clin. Exp. Immunol. 2: 109.Google Scholar
  178. Miller, D. G., 1967, The association of immune disease and malignant lymphoma, Ann. Int. Med. 66: 511.Google Scholar
  179. Miller, J. F. A. P., 1962, Role of the thymus in transplantation, Ann. N.Y. Acad. Sci. 99:340. Miller, J. F. A. P., Grant, G. A., And Roe, F. J. C., 1963, Effect of thymectomy on the induction of skin tumors by 3,4-benzopyrene, Nature (Lond.) 199: 920.Google Scholar
  180. Moloney, J. B., 1962, The murine leukemias, Fed. Proc. 21: 19.PubMedGoogle Scholar
  181. Morgan, J. L., Holcomb, T. M., And Morrissey, R. W., 1968, Radiation reaction in ataxia telangiectasia, Am. J. Dis. Child. 116: 557.PubMedGoogle Scholar
  182. Hlbock, O., And Dux, A., 1971, Histocompatibility genes and susceptibility to mammary tumor virus in mice, Transpl. Proc. 3: 1247.Google Scholar
  183. Murphy, W. H., And Syverton, J. T., 1961, Relative immunologic capacity of leukemic and low-leukemic strains of mice to resist infection, Cancer Res. 21: 921.PubMedGoogle Scholar
  184. Nagaya, H., And Sieker, H. O., 1969, Effects of antithymus serum and antilymphocyte serum on the incidence of lymphoid leukemia, Proc. Soc. Exp. Biol. Med. 131: 891.PubMedGoogle Scholar
  185. Nandi, S., 1967, The histocompatibility-2 locus and susceptibility to Bittner virus borne by red blood cells in mice, Proc. Natl. Acad. Sci. 58: 485.PubMedGoogle Scholar
  186. Nehlsen, S. L., 1971, Immunosuppression, virus and oncogenesis in mice, Transpl. Proc. 3:811. Newman, D. M., And Walter, J. B., 1973, Multiple dermatofibromas in patients with systemic lupus erythematosus on immunosuppressive therapy, New Engl. J. Med. 289: 842.Google Scholar
  187. Notkins, A. L., Mergenhagen, S. E., And Howard, R. J., 1970, Effect of virus infections on the function of the immune system, Ann. Rev. Microbiol. 24: 525.Google Scholar
  188. O’CoNor, G. T., 1970, Persistent immunologic stimulation as a factor in oncogenesis, with special reference to Burkitt’s tumor, Am. J. Med. 48: 279.Google Scholar
  189. Oldstone, M. B. A., Aoki, T., And Dixon, F. J., 1972, The antibody response to murine leukemia virus: Absence of classical immunologic tolerance, Proc. Natl. Acad. Sci. 69: 134.PubMedGoogle Scholar
  190. Oleinick, A., 1969, Altered immunity and cancer risk:A review of the problem and analysis of the cancer mortality experience in leprosy patients, J. Natl. Cancer Inst. 43: 775.PubMedGoogle Scholar
  191. Oren, M. E., And Herberman, R. B., 1971, Delayed cutaneous hypersensitivity reactions to membrane extracts of human tumor cells, Clin. Exp. Immunol. 9: 45.PubMedCentralPubMedGoogle Scholar
  192. Page, A. R., Hansen, A. E., And Good, R. A., 1963, Occurrence of leukemia and lymphoma in patients with agammaglobulinemia, Blood 21: 197.PubMedGoogle Scholar
  193. Pantelouris, F. M., 1968, Absence of thymus in a mouse mutant, Nature (Lond.) 217: 370.Google Scholar
  194. Pekonen, R., Siurala, M., And Vuopio, P., 1963, Inherited agammaglobulinemia with malabsorption and marked alterations in the gastrointestinal mucosa, Acta Med. Scand. 173: 549.Google Scholar
  195. Penn, I., 1970, Malignant Tumors in Organ Transplant Recipients, Springer, New York.Google Scholar
  196. Penn, I., 1974, Malignancies in renal transplant recipients, in: Seventh Miles International Symposium, in press.Google Scholar
  197. Penn, I., And Starzl, T. E., 1972, Malignant tumors arising de novo in immunosuppressed organ transplant recipients, Transplantation 14: 407.PubMedCentralPubMedGoogle Scholar
  198. Penn, I., Hammond, W., Brettschneider, L., And Starzl, T. E., 1969, Malignant lymphomas in transplantation patients, Transpl. Proc. 1: 106.Google Scholar
  199. Peters, R. L., Spahn, G. J., Rabstein, L. S., Kelloff, G. J., And Huebner, R. J., 1973, Neoplasm induction by murine type-C viruses passaged directly from spontaneous non-lymphorecticular tumours, Nature New Biol. 244: 103.PubMedGoogle Scholar
  200. Peterson, R. D. A., Kelly, W. D., And Good, R. A., 1964, Ataxia telangiectasia: Its association with a defective thymus, immunological deficiency disease, and malignancy, Lancet 1: 1189.PubMedGoogle Scholar
  201. Peterson, R. D. A., Cooper, M. D., And Good, R. A., 1966, Lymphoid tissue abnormalities associated with ataxia-telangiectasia, Am. J. Med. 41: 342.PubMedGoogle Scholar
  202. Pincus, T., Rowe, W. P., And Lilly, F., 1971, A major genetic locus affecting resistance to infection with murine leukemia viruses. II. Apparent identity to a major locus described for resistance to Friend murine leukemia virus, J. Exp. Med. 133: 1234Google Scholar
  203. Playfair, J. H. L., 1968, Strain differences in the murine response of mice. I. The neonatal response to sheep red cells, Immunology 15: 35.PubMedGoogle Scholar
  204. Popper, K., 1968, The Logic of Scientific Discovery, Harper and Row, New York.Google Scholar
  205. Potolsky, A. I., Heath, C. W., Buckley, C. E., And Rowlands, D. T., 1971, Lymphoreticular malignancies and immunologic abnormalities in a sibship, Am. J. Med. 50: 42.PubMedGoogle Scholar
  206. Prehn, R. T., 1963, Function of depressed immunological reactivity during carcinogenesis, J. Natl. Cancer Inst. 31: 791.PubMedGoogle Scholar
  207. Prehn, R. T., 1970, Critique of surveillance hypothesis, in: Immune Surveillance ( R. T. Smith and M. Landy, eds.), p. 460, Academic Press, New York.Google Scholar
  208. Prehn, R. T., 1971, Perspectives in oncogenesis: Does immunity stimulate or inhibit neoplasia? J. Reticuloendothel. Soc. 10: 1.PubMedGoogle Scholar
  209. Prehn, R. T., 1972, The immune reaction as a stimulator of tumor growth, Science 176: 170.PubMedGoogle Scholar
  210. Prehn, R. T., And Main, J. M., 1957, Immunity to methylcholanthrene-induced sarcomas, J. Natl. Cancer Inst. 18: 769.PubMedGoogle Scholar
  211. Profitt, M. R., Hirsch, M. S., And Black, P. H., 1973, Absence of cell-mediated immunologic tolerance to leukemia virus in carrier mice, J. Immunol. 110: 1183.Google Scholar
  212. Rabbat, A. G., And Jeejeebhoy, H. F., 1970, Heterologous antilymphocyte serum (Als) hastens theGoogle Scholar
  213. appearance of methylcholanthrene-induced tumours in mice, Transplantation 9:164.Google Scholar
  214. Radl, Masopust, J., Houstek, J., And Hrodek, O., 1967, Paraproteinaemia and unusual dysgamma-globulinemia in a case of Wiskott—Aldrich syndrome: An immunochemical study, Arch. Dis. Child. 42: 608.Google Scholar
  215. Radzichovskaja, R., 1967, Effect of thymectomy on Rous virus tumor growth induced in chickens, Proc. Soc. Exp. Biol. Med. 126: 13.PubMedGoogle Scholar
  216. Reed, N. D., And Jutila, J. W., 1972, Immune response of congenitally thymusless mice to heterologous erythrocytes, Proc. Soc. Exp. Biol. Med. 139: 1234.PubMedGoogle Scholar
  217. Reed, N. D., Manning, J. K., And Rudbach, J. A., 1973, Immunological responsiveness of mice to Lps from Escherichia coli, J. Infect. Diseases (Endotoxin Suppl.).Google Scholar
  218. Reed, W. B., Epstein, W. L., Boder, E., And Sedgwick, R., 1966, Cutaneous manifestations of ataxia telangiectasia, J. Am. Med. Assoc. 195: 746.Google Scholar
  219. Rees, R. B., Bennett, J. H., Hamlin, E. M., And Maibach, H. I., 1964, Aminopterin for psoriasis, Arch. Dermatol. 90: 544.PubMedGoogle Scholar
  220. Reisman, L. E., Mitani, M., And Zuelzer, W. W., 1964, Chromosome studies in leukemia. I. Evidence for the origin of leukemic stem lines from aneuploid mutants, New Engl. J. Med. 270: 591.PubMedGoogle Scholar
  221. Rifkind, D., Marchioro, T. L., And Schneck, S. A., 1967, Systemic fungal infections complicating renal transplantation, Am. J. Med. 43: 28.PubMedGoogle Scholar
  222. RoItt, I., 1971, Essential Immunology, Davis, London.Google Scholar
  223. Rosenberg, S. A., Diamond, H. D., Jaslowitz, B., And Craver, L. F., 1961, Medicine 40: 31.PubMedGoogle Scholar
  224. Rowe, W. P., 1972, Studies of genetic transmission of murine leukemia virus by Akr mice. I. Crosses with Fv-1“ strains of mice, J. Exp. Med. 136: 1272.PubMedCentralPubMedGoogle Scholar
  225. Rowe, W. P., And Hartley, J. W., 1972, Studies of genetic transmission of murine leukemia virus by Akr mice. II. Crosses with Fv-1 5 strains of mice, J. Exp. Med. 136: 1286.PubMedCentralPubMedGoogle Scholar
  226. Rygaard, J., 1969, Immunobiology of the mouse mutant “nude”: Preliminary investigations, Acta Pathol. Microbiol. Scand. 77: 761.PubMedGoogle Scholar
  227. Sahiar, K., And Schwartz, R. S., 1966, The immunoglobulin sequence. II. Histological effects of the suppression of yM and yG antibody synthesis, Int. Arch. Allergy 29: 52.Google Scholar
  228. Saint Geme, J. W., JR., Prince, J. T., Burke, B. A., Good, R. A., And Krivitt, W., 1966, Impaired cellular resistance to herpes-simplex virus in Wiskott—Aldrich syndrome, New Engl. J. Med. 273: 229.Google Scholar
  229. Salaman, M. H., 1969, Immunosuppression by oncogenic viruses, Antibiot. Chemother. 15: 393.PubMedGoogle Scholar
  230. Sanford, B. H., Kohn, H. J., Daly, J.J., And Soo, S. F., 1973, Longterm spontaneous tumor incidence in neonatally thymectomized mice, J. Immunol. 110: 1437.PubMedGoogle Scholar
  231. Sato, H., Boyse, E. A., Aoki, T., Iritani, C., And Old, L. J., 1973, Leukemia associated transplantation antigens related to murine leukemia virus. The X.1 system: immune response controlled by a locus linked to H-2, J. Exp. Med. 138: 593.Google Scholar
  232. Schneck, S. A., And Penn, I., 1970, Cerebral neoplasms associated with renal transplantation, Arch. Neurol. 22: 226.PubMedGoogle Scholar
  233. Schneck, S. A., And Penn, I., 1971, De-novo brain tumors in renal-transplant recipients, Lancet 1: 983.Google Scholar
  234. Schwartz, R. S., 1965, Immunosuppressive drugs, Prog. Allergy 9: 246.Google Scholar
  235. Schwartz, R. S., 1971, Immunoregulation by antibody, Prog. Immunol. 1: 1081.Google Scholar
  236. Schwartz, R. S., 1972, Immunoregulation, oncogenic viruses and malignant lymphomas, Lancet 1: 1266.PubMedGoogle Scholar
  237. Shachat, D. A., Fefer, A., And Moloney, J. B., 1968, Effect of cortisone on oncogenesis by murine sarcoma virus (Moloney), Cancer Res. 28: 517.PubMedGoogle Scholar
  238. Sharpstone, P., Ogg, C. S., And Cameron, J. S., 1969, Nephrotic syndrome due to primary renal disease in adults. II. A controlled trial of prednisone and azathioprine, Brit. Med. J. 2: 535.PubMedGoogle Scholar
  239. Shearer, G, M., Mozes, E., Haran-Ghera, N., And Bentwich, Z., 1973, Cellular analysis of immunosuppression to synthetic polypeptide immunogens induced by a murine leukemia virus, J. Immunol. 110: 736.Google Scholar
  240. Shuster, J., Hart, Z., Stimson, C. W., Brough, A. J., And Poulik, M. D., 1966, Ataxia telangiectasia with cerebellar tumor, Pediatrics 37: 776.PubMedGoogle Scholar
  241. Siegler, R., 1968, Pathology of murine leukemias, in: Experimental Leukemia ( M. A. Rich, ed.), p. 51, Appleton-Century-Crofts, New York.Google Scholar
  242. SJÖGren, H. O., And Borum, K., 1971, Tumor-specific immunity in the course of primary polyoma and Rous tumor development in intact and immunosuppressed rats, Cancer Res. 31: 890.PubMedGoogle Scholar
  243. SJÖGren, H. O., HellstrÖM, I., Bansal, S. C., And HellstrÖM, K. E., 1971, Suggestive evidence that the “blocking antibodies” of tumor-bearing individuals may be antigen—antibody complexes, Proc. Natl. Acad. Sci. 68: 1372.PubMedGoogle Scholar
  244. Staples, P. J., And Talal, N., 1969, Relative inability to induce tolerance in adult Nzb and Nzb/Nzw F1 mice, J. Exp. Med. 129: 123.Google Scholar
  245. Starzl, T. E., Penn, I., Putnum, C. W., Groth, C. G., And Halgrimson, C. G., 1971, Iatrogenic alterations of immunologic surveillance in man and their influence on malignancy, Transpl. Rev. 7: 112.Google Scholar
  246. Stjernsward, J., 1965, Immunodepressive effect of 3-methylcholanthrene: Antibody formation at cellular level and reaction against weakly antigenic homografts, J. Natl. Cancer Inst. 35: 885.PubMedGoogle Scholar
  247. Stjernsward, J., 1966, Effect of non-carcinogenic and carcinogenic hydrocarbons on antibody forming cells measured at cellular level in vitro, J. Natl. Cancer Inst. 36: 1189.Google Scholar
  248. Stjernsward, J., 1967, Further immunological studies of chemical carcinogenesis, J. Natl. Cancer Inst. 38: 515.PubMedGoogle Scholar
  249. Stjernsward, J., 1969, Immunosuppression by carcinogens, Antibiot. Chemother. 15: 213.PubMedGoogle Scholar
  250. Stjernsward, J., Jondal, M., Vanky, F., Wigzell, H., And Sealy, R., 1972, Lymphopenia and change in distribution of human B and T lymphocytes in peripheral blood induced by irradiation for mammary carcinoma, Lancet 1: 1352.Google Scholar
  251. Strum, S. B., Park, J. K., And Rappaport, H., 1970, Observation of cells resembling Sternberg—Reed cells in conditions other than Hodgkin’s disease, Cancer 26: 176.PubMedGoogle Scholar
  252. Stutman, O., 1969, Carcinogen-induced immune depression: Absence in mice resistant to chemical oncogenesis, Science 166: 620.PubMedGoogle Scholar
  253. Stutman, O., And Dupuy, J. M., 1972, Resistance to Friend leukemia virus in mice: Effect of immunosuppression, J. Natl. Cancer Inst. 49: 1283.PubMedGoogle Scholar
  254. Stutman, O., Yunis, E. J., And Good, R. A., 1968, Deficient immunologic functions of Nzb mice, Proc. Soc. Exp. Biol. Med. 127: 1204.Google Scholar
  255. Swanson, M., And Schwartz, R. S., 1967, Immunosuppressive therapy: The relation between clinical response and immunologic competence, New Engl. J. Med. 277: 163.PubMedGoogle Scholar
  256. Szakal, A. K., And Hanna, M. G., 1972, Immune suppression and carcinogenesis in hamsters during topical application of 7,12-dimethylbenz(a)anthracene, in: Conference on Immunology of Carcinogenesis, p. 173, National Cancer Institute Monograph 35, National Cancer Instute, Bethesda, Md.Google Scholar
  257. Talal, N., And Bunim, J. J., 1964, The development of malignant lymphoma in the course of Sjögren’s syndrome, Am. J. Med. 36: 529.PubMedGoogle Scholar
  258. Tales, N., Tohme, S., Ghostine, S., Barmada, B., And Nahas, S., 1969, Association d’une ataxie telangiectasie avec une leucemie aigue lymphoblastique, Presse Med. 77: 345.Google Scholar
  259. Teague, P. 0., Yunis, E. J., Rodey, G., Fish, A. J., Stutman, O., And Good, R. A., 1970, Autoimmune phenomena and renal disease in mice: Role of thymectomy, aging and involution of immunologic capacity, Lab. Invest. 22: 121.PubMedGoogle Scholar
  260. Ten Bensel, R. W., Stadlan, E. M., And Krivit, W., 1966, The development of malignancy in the course of the Aldrich syndrome, J. Pediat. 68: 761.PubMedGoogle Scholar
  261. Tennant, J. R., And Snell, G. D., 1968, The H-2locus and viral leukemogenesis as studied in congenic strains of mice, J. Natl. Cancer Inst. 41: 597.PubMedGoogle Scholar
  262. Thomas, L., 1959, Discussion, in: Cellular and Humoral Aspects of the Hypersensitive States ( H. S. Lawrence, ed.), pp. 529–532, Hoeber-Harper, New York.Google Scholar
  263. Ting, R. C., 1966, Effect of thymectomy on transplantation resistance induced by polyoma tumor homografts, Nature (Lond.) 211: 1000.Google Scholar
  264. Ting, R. C., 1967, Tumor induction in thymectomized rats by murine sarcoma virus (Moloney) and properties of the induced virus-free tumor cells, Proc. Soc. Exp. Biol. Med. 126: 778.Google Scholar
  265. Ting, R. C., And Law, L. W., 1965, The role of thymus in transplantation resistance induced by polyoma virus, J. Natl. Cancer Inst. 34: 521.PubMedGoogle Scholar
  266. Todaro, G. J., And Huebner, R. J., 1972, The viral oncogene hypothesis: New evidence, Proc. Natl. Acad. Sci. 69: 1009.PubMedGoogle Scholar
  267. Trainin, N., And Linker-Israeli, M., 1971, Increased incidence of spontaneous lung adenomas in mice following neonatal thymectomy, Israel J. Med. Sci. 7: 36.PubMedGoogle Scholar
  268. Turk, J. L., And Bryceson, D. M., 1971, Immunological phenomena in leprosy and related diseases, Advan. Immunol. 13: 209.Google Scholar
  269. Twomey, J. J., Jordan, P. H., Laughter, A. H., Meuwissen, H. J., And Good, R. A., 1970, The gastric disorder in immunoglobulin-deficient patients, Ann. Int. Med. 72: 499.PubMedGoogle Scholar
  270. Vandeputte, M., 1969, Antilymphocyteserum and polyoma oncogenesis in rats, Transpl. Proc. 1: 100.Google Scholar
  271. Vandeputte, M., And DE Somer, P., 1965, Influence of thymectomy on viral oncogenesis in rats, Nature (Land.) 206: 520.Google Scholar
  272. Van Hoosier, G. L., Gist, C., And Trentin, J. J., 1968, Enhancement by thymectomy of tumor formation by oncogenic adenoviruses, Proc. Soc. Exp. Biol. Med. 128: 467.PubMedGoogle Scholar
  273. Varet, B., Levy, J. P., Leclerc, J. C., And Kourilsky, F. M., 1971, Effect of antithymocytic serum on viral leukemia, erythroblastosis, and sarcoma in mice, Int. J. Cancer 7: 313.PubMedGoogle Scholar
  274. Vredevoe, D. L., And Hays, E. F., 1969, Effect of antilymphocytic and antithymocytic sera on the development of mouse lymphoma, Cancer Res. 29: 1685.PubMedGoogle Scholar
  275. Wagner, J. L., And Haughton, G., 1971, Immunosuppression by antilymphocyte serum and its effects on tumors induced by 2-methylcholanthrene in mice, J. Natl. Cancer Inst. 46: 1.PubMedGoogle Scholar
  276. Wahren, B., And Metcalf, D., 1970, Cytotoxicity in vitro of preleukaemic lymphoid cells on syngeneic monolayers of embryo or thymus cells, Clin. Exp. Immunol. 7: 373.PubMedCentralPubMedGoogle Scholar
  277. Walder, B. K., Robertson, M. R., And Jeremy, D., 1971, Skin cancer and immunosuppression, Lancet 2: 1282.PubMedGoogle Scholar
  278. Waldmann, T. A., Strober, W., And Blaese, R. M., 1972, Immunodeficiency disease and malignancy, Ann. Int. Med. 77: 605.Google Scholar
  279. Waldorf, D. S., Sheagren, J. N., Trautman, J. R., And Block, J. B., 1966, Impaired delayed hypersensitivity in patients with lepromatous leprosy, Lancet 2: 773.PubMedGoogle Scholar
  280. Weiden, P. L., Blaese, R. M., Strober, W., Block, J. B., And Waldmann, T. A., 1972, Impaired lymphocyte transformation in intestinal lymphangiectasia: Evidence for at least two functionally distinct lymphocyte populations in man, J. Clin. Invest. 51: 1319.PubMedCentralPubMedGoogle Scholar
  281. Weir, D. M., Mcbride, W., And Naysmith, J. D., 1968, Immune response to a soluble protein antigen in Nzb mice, Nature (Land.) 219: 1276.Google Scholar
  282. Woods, D. A., 1969, Influence of antilymphocyte serum on Dmba induction of oral carcinomas, Nature (Lond.) 224: 276.Google Scholar
  283. Wortis, H. H., 1971, Immunological responses of “nude” mice, Clin. Exo. Immunol. 8: 305.Google Scholar
  284. Wortis, H. H., Nehlsen, S., And Owen, J. J., 1971, Abnormal development of the thymus in “nude” mice, J. Exp. Med. 134: 681.Google Scholar
  285. Young, R. R., Austen, K. F., And Moser, H. W., 1964, Abnormalities of serum gamma-1-A globulin and ataxia telangiectasia, Medicine 43: 423.PubMedGoogle Scholar
  286. Ytredal, D. O., And Bradfield, J. S., 1972, Seminoma of the testicle: Prophylactic mediastinal irradiation versus periaortic and pelvic irradiation alone, Cancer 30: 628.PubMedGoogle Scholar
  287. Yunis, E. J., Martinez, C., Smith, J., Stutman, O., And Good, R. A., 1969, Spontaneous mammary adenocarcinoma in mice:Influence of thymectomy and reconstitution with thymus grafts or spleen cells, Cancer Res. 29: 174.PubMedGoogle Scholar
  288. Zatz, M. M., Mellors, R. C., And Lance, E. M., 1971, Changes in lymphoid populations of aging Cba and Nzb mice, Clin. Exp. Immunol. 8: 491.PubMedCentralPubMedGoogle Scholar
  289. Zisblatt, M., And Lilly, F., 1972, The effect of immunosuppression on oncogenesis by murine sarcoma virus, Proc. Soc. Exp. Biol. Med. 141: 1036.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1982

Authors and Affiliations

  • Cornelis J. M. Melief
    • 1
  • Robert S. Schwartz
    • 1
  1. 1.Hematology Service, New England Medical Center Hospital, and the Department of MedicineTufts University School of MedicineBostonUSA

Personalised recommendations